
Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.
Investor Presentation Deck
Tetra Investor Presentation
Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.
Investor Presentation Deck
Tetra Investor Presentation
The event further establishes LALPINA CBD’s connection to professional athletes as the Company looks to penetrate the $30 billion US fitness market PLAYA VISTA, Apr 25, 2019 – American Premium Water Corporation(OTC: HIPH) announces that […]
PLAYA VISTA, May 09, 2019 – American Premium Water Corporation (OTC: HIPH) CEO Ryan Fishoff provides an update to shareholders on the Company’s progress in the 1 quarter and outlook for the rest of the year. […]
Canaccord Genuity 2nd Annual U.S. Cannabis Symposium Conference on October 3, 2019 in Toronto, Canada- Alliance Global Partners Consumer Cannabis Conference on October 3, 2019 in New York City- Company to share its growth strategy […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.